Press Releases

Varian Unveils Innovative New Solution for Adaptive Therapy

Strengthening its leadership in delivering innovative new solutions to transform cancer care globally, Varian (NYSE: VAR) today announced Ethos™ therapy, an Adaptive Intelligence™ solution....

Varian and Oncora Partner to Accelerate Precision Medicine in Radiation Oncology

Varian (NYSE: VAR) today announced it is investing in Oncora Medical and partnering to accelerate the development of software tools to enable precision medicine in radiation oncology. Oncora is a...

Varian Announces Fourth Quarter Fiscal Year 2019 Earnings Release Date

Varian (NYSE: VAR) today announced its fourth quarter fiscal year 2019 earnings release date. The Company will report results for the fourth quarter of fiscal year 2019 after market close on...

Varian Expects to Benefit from Linear Accelerator Tariff Exclusion in China

Varian (NYSE: VAR) has received notice from the Customs Tariff Commission of the State Council of China that medical linear accelerators are excluded from the additional tariffs China imposed on...

Varian-equipped New York Proton Therapy Center Treats First Patients

The New York Proton Center (NYPC) has treated its first proton therapy cancer patients. Equipped with the Varian ProBeam® proton therapy system, NYPC is New York State's first proton therapy...

Cyclotron for Varian ProBeam Compact Proton Therapy System Installed at Sylvester Comprehensive Cancer Center

Varian (NYSE: VAR) has completed the installation of the cyclotron for its ProBeam® Compact single-room proton therapy system at Sylvester Comprehensive Cancer Center at the University of Miami...

Dr. Phil Febbo Named to Varian Board of Directors

Varian (NYSE: VAR) today announced that Phil Febbo, MD, chief medical officer (CMO) at Illumina has been appointed to the Varian Board of Directors, effective August 16, 2019. "We are proud to...

Varian Completes Purchase of Embolic Bead Asset

Varian (NYSE: VAR) today announced it has successfully completed its asset purchase of the Boston Scientific portfolio of microsphere and bland embolic bead products for treating...

Varian to Hold Investor Day in New York City

Varian (NYSE: VAR) today announced that its executive management team will be hosting an Investor Day on Friday, November 15, 2019 at The Plaza Hotel, Fifth Avenue at Central Park South, New York,...

Varian to Host Investor Meeting at ASTRO in Chicago

Varian (NYSE: VAR) today announced that its executive staff will be meeting with analysts and investors at the American Society for Radiation Oncology (ASTRO) Annual Meeting in Chicago on Monday,...